DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Levetiracetamis the generic ingredient in six branded drugs marketed by Ucb Inc, Akorn, Am Regent, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Hainan Poly Pharm, Hikma Farmaceutica, Hospira Inc, Jubilant Generics, Micro Labs, Mylan Labs Ltd, Sagent Pharms, Sun Pharm Inds Ltd, Xgen Pharms, Gland Pharma Ltd, Hq Speciality Pharma, Nexus Pharms, Aci Healthcare Ltd, Actavis Mid Atlantic, Alembic Labs, Amneal Pharms, Anda Repository, Apotex Inc, Breckenridge, Hetero Labs Ltd Iii, Lannett Co Inc, Lupin Ltd, Pharm Assoc, Taro, Tris Pharma Inc, Wockhardt Bio Ag, Tripoint, Actavis Elizabeth, Actavis Labs Fl Inc, Anchen Pharms, Apotex, Florida, Hisun Pharm Hangzhou, Lotus Pharm Co Ltd, Mylan Pharms Inc, Overseas, Pharma Life, Pharmadax Inc, Prinston Inc, Rouses Point Pharms, Sandoz, Sciegen Pharms Inc, Sun Pharm, Sun Pharm Industries, Teva Pharms, Torrent Pharms Ltd, Virtus Pharms, Aprecia Pharms, Accord Hlthcare, Aurobindo Pharma, Chartwell Rx, Dr Reddys Labs Ltd, Fosun Pharma, Invagen Pharms, Lupin, Mylan, Nostrum Labs Inc, Orchid Hlthcare, Oxford Pharms, Secan Pharms, Torrent Pharms, Viwit Pharm, Vkt Pharma, Watson Labs Inc, Wockhardt, Zhejiang Jingxin, and Zydus Pharms Usa Inc, and is included in ninety-six NDAs. There are nine patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.
Levetiracetam has ninety-three patent family members in thirty countries.
There are thirty-five drug master file entries for levetiracetam. Eighty-one suppliers are listed for this compound. There are two tentative approvals for this compound.
Summary for LEVETIRACETAM
|Drug Master File Entries:||35|
|Finished Product Suppliers / Packagers:||81|
|Raw Ingredient (Bulk) Api Vendors:||118|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price trends for LEVETIRACETAM|
|Drug Sales Revenues:||Drug sales revenues for LEVETIRACETAM|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for LEVETIRACETAM|
|What excipients (inactive ingredients) are in LEVETIRACETAM?||LEVETIRACETAM excipients list|
|DailyMed Link:||LEVETIRACETAM at DailyMed|
Recent Clinical Trials for LEVETIRACETAM
Identify potential brand extensions & 505(b)(2) entrants
|CureRareDisease LLC||Phase 1/Phase 2|
|Janssen Research & Development, LLC||Phase 2|
|University of Cambridge||Phase 3|
Generic filers with tentative approvals for LEVETIRACETAM
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for LEVETIRACETAM
|Physiological Effect||Decreased Central Nervous System Disorganized Electrical Activity |
|Country||Patent Number||Estimated Expiration|
|China||1856299||⤷ Try it Free|
|Japan||2016514680||⤷ Try it Free|
|African Regional IP Organization (ARIPO)||200603602||⤷ Try it Free|
|Denmark||1909764||⤷ Try it Free|
|New Zealand||556630||⤷ Try it Free|
|China||105188849||⤷ Try it Free|
|Norway||20074316||⤷ Try it Free|
|>Country||>Patent Number||>Estimated Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|0162036||C300028||Netherlands||⤷ Try it Free||PRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929|
|0162036||2000C/032||Belgium||⤷ Try it Free||PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.